The Paul and Diane Manning Institute of Biotechnology

The Paul and Diane Manning Institute of Biotechnology will focus and project the University’s commitment to research in biotechnology by promoting collaborative science and establishing a state-of-the-art campus centered on the research, development, commercialization, manufacturing, and patient care of new, innovative cellular, gene, and immuno-therapies. The Institute will provide a confluence of researchers and scientific leaders from all biomedical, engineering, and chemical sciences at the University and amplify opportunities for students and faculty to be at the frontlines of science and technology. 

Our Leadership

K. Craig Kent, EVP for Health Affairs

Ian Baucom, EVP and Provost 

Frederick H. Epstein, Interim VP for Research

Executive Director

We have launched the search for an inaugural executive director to lead the institute.

Please see position description here. If you are interested in applying for the position, please contact Alana Aisthorpe at Korn Ferry: [email protected]


Paul and Diane Manning

Paul Manning, an entrepreneur with 30 years of experience in the health care industry, founded PBM Capital in 2010. In 1997, he founded PBM Products, which became the largest private label producer of infant formula and baby/toddler food in the world. Manning is an active member of the UVA community, having served on the UVA Strategic Planning Committee, the UVA Health Foundation, the President’s Advisory Committee, and the Honor the Future Campaign Executive Committee. Manning was named Virginia Entrepreneur of the Year by Ernst and Young in 2002. The Manning family has been a longtime supporter of UVA and UVA Health's research efforts.

Paul and Diane Manning